A Phase 1B Study of BZLF1 Peptide Vaccine in Solid Organ Transplant Patients
Recruiting Phase 1 NCT06741072
Study Description
A Study to Evaluate the Safety and Effectiveness of a Vaccine to Prevent Epstein-Barr Virus-Related Cancer in Patients Awaiting Solid Organ Transplants
Study Details
- Registry ID:
- NCT06741072
- Conditions:
- Chronic Kidney Disease, Stage 4, Chronic Kidney Disease, Stage 5, EBV-Related Lymphoproliferative Disorder, EBV-Related Malignant Neoplasm, Post-Transplant Lymphoproliferative Disorder
- Phase:
- Phase 1
- Target Enrollment:
- 55 participants
- Start Date:
- Age Range:
- 18–65 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.